Navigating by the Stars To Achieve a Brighter Future for Hometown Scientists
In 2013, to avoid monitoring by his manager, a truck driver at a New Jersey engineering firm purchased an illegal $50 GPS jammer that plugged into his vehicle's cigarette lighter. The device inadvertently also jammed the satellite system navigation capabilities of the entire Newark airport every time he drove by. The signals emanating from the vehicle were blocking the reception of GPS frequencies used by the air traffic control system, and planes were unable to safely land or take off, forcing the airport to close.
'People don't realize how vulnerable GPS is,' said Dr. Joshua Morales, owner and founder of StarNav, a startup tech company that provides hardware and software solutions enabling safe, reliable positioning and timing. 'StarNav's products convert terrestrial and low-Earth orbit satellite signals into reliable positioning and timing information, working even when GPS fails. Because GPS is used in critical U.S. infrastructure, such as time keeping, currency, communication, navigation, and energy, having a secondary way for keeping the country synchronized is an imperative.'
Navigational guidance by the stars is an ancient concept, but Morales and his team are innovating navigation for the future, and this work-with-what-you-have ethos has shaped much of Morales' journey. As part of this he is determined to keep his company in the Inland Empire area of Southern California, in order to create a profitable career hub for brilliant scientific minds who graduate from the areas many universities, rather than feeding into the intellectual exodus to the Silicon Valley that Inland Empire scientists currently face. StarNav began at one such local institution, the University of California, Riverside (UCR) as part of their Entrepreneurship Center (EPIC) which specializes in providing training, mentorship and access to capital to innovative, technology intensive businesses.
Over the past two years, U.S. Bank provided corporate contributions totaling $95,000 in support of UCR's Zero-to-Entrepreneur program, which is part of the SoCal OASIS™ regional economic development strategy focused on sustainability, innovation, social inclusion and workforce development in Inland Southern California and home to StarNav's early beginnings.
Morales earned his Ph.D. from UC Irvine in 2020. After completing his doctorate, he returned to Riverside, which is where attended UCR for his B.S. in Electrical Engineering. He has been a part of the vibrant innovation hub on the campus since beginning StarNav, which is where he also met U.S. Bank Business Access Advisor, and fellow Inland Empire native, Heli Castaneda.
'It has been a joy to support the business owners and students who participate in the programs at UCR,' said Castaneda.
As a native of the Inland Empire who is raising his children there, Castaneda shares Morales' desire to invest in his community.
'This is where I have the privilege of being able to be of service to local businesses and students,' Castaneda said. 'My role at U.S. Bank is all about bringing information, resources, and building bridges. My services are offered for free, and entrepreneurs don't have to be a U.S. Bank customer to work with me, and I really enjoy that part of my job! I'm here to help everyone.'
The relationship between U.S. Bank and UCR began with the work of Inland Southern California community affairs manager Rossina Gallegos, who saw the vision to empower Inland Empire residents, particularly underserved individuals, to launch high-growth, sustainably focused technology startups that create quality jobs. The program's first year concluded in March 2024 and received glowing participant feedback, with many calling it 'immensely valuable.' In addition to the funding, in 2023 and 2024 small business specialists from U.S. Bank participated in the selection of the SoCal OASIS Pitch Competition to help select the award winners of the program.
'At U.S. Bank, our whole mission is to invest our hearts and minds into powering human potential,' Gallegos said. 'We are happy to be able to support programs that serve brilliant students and innovative entrepreneurs who are equally invested in making our Inland Empire communities a better place to live and work.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
See How Money Flows Drive Outliers Like Garmin
GRMN builds GPS equipment and wearable technology, focusing on automotive, aviation, marine, outdoors, and fitness markets. Its first-quarter fiscal 2025 earnings report showed record quarterly revenue of $1.54 billion (up 11% in a year), $333 million in operating income (up 12%), and per-share earnings of $1.61 (up 13%). No wonder GRMN shares are up 12% so far this year – and they could rise more. MoneyFlows data shows how Big Money investors are again betting heavily on the stock. Big Money Heads to Garmin Institutional volumes reveal plenty. In the last year, GRMN has enjoyed strong investor demand, which we believe to be institutional support. Each green bar signals unusually large volumes in GRMN shares. They reflect our proprietary inflow signal, pushing the stock higher: Plenty of technology names are under accumulation right now. But there's a powerful fundamental story happening with Garmin. Garmin Fundamental Analysis Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, GRMN has had strong sales and earnings growth: 1-year sales growth rate (+20.4%) 3-year EPS growth rate (+10.7%) Source: FactSet Also, EPS is estimated to ramp higher this year by +5.8%. Now it makes sense why the stock has been generating Big Money interest. GRMN has a track record of strong financial performance. Marrying great fundamentals with MoneyFlows software has found some big winning stocks over the long term. Garmin has been a top-rated stock at MoneyFlows for years. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis. It's up 3,840% since its first appearance on the rare Outlier 20 report in December 2002. The blue bars below show when GRMN was a top pick…Big Money loves it: Tracking unusual volumes reveals the power of money flows. This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward. Garmin Price Prediction The GRMN action isn't new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio. Disclosure: the author owns GRMN in personal and managed accounts at the time of publication. If you are a Registered Investment Advisor (RIA) or a serious investor, learn how institutional trading flows can take your investing to the next level. This article was originally posted on FX Empire More From FXEMPIRE: Eye Outliers Like Synopsys Early with Money Flows EU's Sluggish Economy Faces Moderate Growth Slowdown from US Trade Tensions Germany: Successful Implementation of Infrastructure Investment Key to Growth, Fiscal Sustainability Buy Like Big Money: Carpenter Technology Soars SoFi Shares See Huge Bullish Signal, Could Rise More Coinbase on Fire from Sustained Big Money Buys Inicia sesión para acceder a tu cartera de valores
Hamilton Spectator
2 days ago
- Hamilton Spectator
PharmAla Issues Q3 Financial Statements
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. ('PharmAla' or the 'Company') (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for the period ended May 31, 2025. All figures are reported in Canadian dollars. The Company's full set of unaudited condensed interim consolidated financial statements for the quarter and accompanying management's discussion and analysis can be accessed by visiting the Company's website at and its profile page on SEDAR+ at . 'The re-opening of PharmAla's domestic Canadian distribution has allowed us to execute as much volume in Q2 and Q3 as we did in all of the last fiscal year. The creation of our Prescriber's Portal has also allowed us to build a much closer relationship with our doctor customers, which we believe will serve us well moving forward,' said Nick Kadysh, CEO, PharmAla Biotech. 'As we move into the last quarter of Fiscal '24-25, we are incredibly pleased that a large shipment of LaNeo MDMA has arrived at our US distribution partner for delivery to a considerable group of clinical trial customers, most previously announced. PharmAla is also pleased to announce the completion of a manufacturing run in Australia for our 40mg LaNeo Capsules. These capsules were jointly manufactured for both Cortexa's use within Australia and PharmAla's use worldwide, and our improved manufacturing process should yield operational benefits well into the future.' Financial Highlights: 'Over the past quarter, our team has made exciting progress to ensure a reliable supply of pharmaceutical product for both researchers in clinical trials and patients in need of treatment,' said Will Avery, CFO, PharmAla Biotech. 'Our Prescriber Platform continues to empower physicians to access the MDMA and provide treatment for their patients and we look forward to additional clinical trial fulfillment to US and international customers in the near term, unburdened by cross-border trade issues.' About PharmAla PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) is a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, including MDMA. PharmAla was founded with a dual focus: alleviating the global backlog of generic, clinical-grade MDMA to enable clinical trials as well as commercial sales in selected jurisdictions, and to develop novel drugs in the same class. PharmAla is the only company currently provisioning clinical-grade MDMA for patient treatments outside of clinical trials. PharmAla's research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. PharmAla is a 'regulatory first' organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators. For more information, please contact: Nicholas Kadysh Chief Executive Officer PharmAla Biotech Holdings Inc. Email: press@ Phone: 1-855-444-6362 Website: Neither the CSE nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release. Cautionary Note Regarding Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as 'plans', 'strategy', 'expects' or 'does not expect', 'intends', 'continues', 'anticipates' or 'does not anticipate', or 'believes', or variations of such words and phrases or may contain statements that certain actions, events or results 'will be taken', 'will launch' or 'will be launching', 'will include', 'will allow', 'will be made' 'will continue', 'will occur' or 'will be achieved'. We direct readers to refer to the 'Caution Regarding Forward-Looking Statements' contained within the Company's management's discussion and analysis for the period ended May 31, 2025, as filed on Sedar+ . Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. Although the Company believes that the expectations reflected in these statements are reasonable, such statements are based on expectations, factors, and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company's control, including but not limited to the risk factors discussed in the Company's management's discussion and analysis, and elsewhere in this press release, as such factors may be further updated from time to time in our periodic filings, available at , which factors are incorporated herein by reference. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results, or otherwise, or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.
Business Wire
2 days ago
- Business Wire
Sandisk Forms HBF™ Technical Advisory Board to Guide Development and Strategy for High-Bandwidth Flash Memory Technology
MILPITAS, Calif.--(BUSINESS WIRE)--Sandisk Corporation (NASDAQ: SNDK) today announced the formation of a Technical Advisory Board to guide the development and strategy of its groundbreaking High Bandwidth Flash (HBF™) memory technology. The board includes industry experts and senior technical leaders from both within and outside the company. Appointed today, Professor David Patterson and Raja Koduri will provide strategic guidance, technical insight, market perspective, and shape open standards as Sandisk prepares to launch HBF. 'We're honored to have two distinguished computer architecture experts join our Technical Advisory Board,' said Alper Ilkbahar, Executive Vice President, Chief Technology Officer, and HBF Technical Advisory Board member at Sandisk. 'Their collective experience and strategic counsel will be instrumental in shaping HBF as the future memory standard for the AI industry, and affirming we not only meet but exceed the expectations of our customers and partners.' Professor David Patterson, Pardee Professor of Computer Science, Emeritus at the University of California at Berkeley and a Google distinguished engineer, will lead the Technical Advisory Board and guide the group toward actionable insights and decisions. He is a prominent computer scientist known for co-developing Reduced Instruction Set Computing (RISC), which revolutionized processor design. He played key roles in the development of Redundant Array of Inexpensive Disks (RAID), and Networks of Workstations (NOW). Patterson co-authored the seminal textbook Computer Architecture: A Quantitative Approach and was also awarded the 2017 ACM Turing Award for his contributions to the industry. 'HBF shows the promise of playing an important role in datacenter AI by delivering unprecedented memory capacity at high bandwidth, enabling inference workloads to scale far beyond today's constraints,' said Professor Patterson. 'It could drive down costs of new AI applications that are currently unaffordable.' Raja Koduri is a computer engineer and business executive renowned for leading graphics architecture, with previous positions at AMD as Senior Vice President and Chief Architect and at Intel as Executive Vice President of Accelerated Computing Systems and Graphics. He directed the development of AMD's Polaris, Vega, and Navi GPU architectures, Intel's Arc and Ponte Vecchio GPUs, and spearheaded Intel's foray into discrete graphics. In early 2023, he founded a startup focused on generative AI for gaming, media, and entertainment, and joined the Board of Tenstorrent in the AI and RISC‑V semiconductor space. Most recently, he serves as Founder/CEO of Oxmiq Labs and Co-Founder of Mihira Visual Studios and continues to shape graphics and AI innovation through advisory and board roles across the semiconductor industry. 'HBF is set to revolutionize edge AI by equipping devices with memory capacity and bandwidth capabilities that will support sophisticated models running locally in real time,' said Koduri. 'This advancement will unlock a new era of intelligent edge applications, fundamentally changing how and where AI inference is performed.' Introduced at Future FWD: Sandisk 2025 Investor Day, HBF is a breakthrough memory solution designed to augment High Bandwidth Memory (HBM) for AI inference workloads, offering comparable bandwidth while delivering up to 8x the capacity at a similar cost. Enabled by BiCS technology and CBA wafer bonding, HBF leverages proprietary stacking with ultra-low die warpage for 16-high configurations. Its architecture has been developed over the past year with input from leading AI industry players. For more information about HBF, please visit this Fact Sheet. About Sandisk Sandisk (Nasdaq: SNDK) delivers innovative Flash solutions and advanced memory technologies that meet people and businesses at the intersection of their aspirations and the moment, enabling them to keep moving and pushing possibility forward. Follow Sandisk on Instagram, Facebook, X, LinkedIn, and YouTube. Join TeamSandisk on Instagram. Sandisk and the Sandisk logo are registered trademarks or trademarks of Sandisk Corporation or its affiliates in the U.S. and/or other countries. All other marks are the property of their respective owners. Product specifications subject to change without notice. © 2025 Sandisk Corporation or its affiliates. All rights reserved.
